How To Address Challenges In Oncology Drug Containment
By T. Page McAndrew

Drug product containment systems comprising Daikyo Crystal Zenith® cyclic olefin polymer (COP) vials have advantages over those comprising glass vials. When matched with NovaPure® stoppers, container closure integrity (CCI) performance has been quantified for oxygen and carbon dioxide, at temperatures from room temperature through cryogenic temperatures, with excellent system performance. For these reasons, they are an excellent choice for oncology therapies, in particular those based on gene and cell therapies that require cryogenic storage.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
West Pharmaceutical Services, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more